The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Comparison of Apoptosis in Wild-Type and Fas-Resistant Cells: Chemotherapy-Induced Apoptosis Is Not Dependent on Fas/Fas Ligand Interactions
Open accessAbstract
The Fas/Fas ligand (FasL) pathway is widely involved in apoptotic cell death in lymphoid and nonlymphoid cells. It has recently been postulated that many chemotherapeutic agents also induce cell death by activating the Fas/FasL pathway. In the present study we compared apoptotic pathways induced by anti-Fas or chemotherapeutic agents in the Jurkat human T-cell leukemia line. Immunoblotting showed that treatment of wild-type Jurkat cells with anti-Fas or the topoisomerase II-directed agent etoposide resulted in proteolytic cleavage of precursors for the cysteine-dependent aspartate-directed proteases caspase-3 and caspase-7 and degradation of the caspase substrates poly(ADP-ribose) polymerase (PARP) and lamin B1 . Likewise, affinity labeling with N-(Nα-benzyloxycarbonylglutamyl-Nε-biotinyllysyl)aspartic acid [(2,6-dimethyl-benzoyl)oxy]methyl ketone [Z-EK (bio)D-amok] labeled the same five active caspase species after each treatment, suggesting that the same downstream apoptotic pathways have been activated by anti-Fas and etoposide. Treatment with ZB4, an antibody that inhibits Fas-mediated cell death, failed to block etoposide-induced apoptosis, raising the possibility that etoposide does not initiate apoptosis through Fas/FasL interactions. To further explore the relationship between Fas- and chemotherapy-induced apoptosis, Fas-resistant Jurkat cells were treated with various chemotherapeutic agents. Multiple independently derived Fas-resistant Jurkat lines underwent apoptosis that was indistinguishable from that of the Fas-sensitive parental cells after treatment with etoposide, doxorubicin, topotecan, cisplatin, methotrexate, staurosporine, or γ-irradiation. These results indicate that antineoplastic treatments induce apoptosis through a Fas-independent pathway even though Fas- and chemotherapy-induced pathways converge on common downstream apoptotic effector molecules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
Nagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,938
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., & Earnshaw, W. C. (1994) · Nature · doi:10.1038/371346a0 · Cited by 2,562
Self-citationHuman ICE/CED-3 Protease Nomenclature
Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W., & Yuan, J. (1996) · Cell · doi:10.1016/s0092-8674(00)81334-3 · Cited by 2,372
Boldin, M. P., Goncharov, T. M., Goltseve, Y. V., & Wallach, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81265-9 · Cited by 2,292
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
Dhein, J., Walczak, H., Bäumler, C., Debatin, K.-M., & Krammer, P. H. (1995) · Nature · doi:10.1038/373438a0 · Cited by 1,609
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996) · Science · doi:10.1126/science.274.5291.1363 · Cited by 1,249
Friesen, C., Herr, I., Krammer, P. H., & Debatin, K.-M. (1996) · Nature Medicine · doi:10.1038/nm0596-574 · Cited by 974
Kaufmann, S. H. (1989) · PubMed · Cited by 922
Self-citationBcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
Miyashita, T., & Reed, J. (1993) · Blood · doi:10.1182/blood.v81.1.151.151 · Cited by 882
Barry, M. A., Behnke, C. A., & Eastman, A. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90733-2 · Cited by 867
Müller, M., Strand, S., Hug, H., Heinemann, E. M., Walczak, H., Hofmann, W. J., Stremmel, W., Krammer, P. H., & Galle, P. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119174 · Cited by 748
Fernandes-Alnemri, T., Armstrong, R. C., Krebs, J., Srinivasula, S. M., Wang, L., Bullrich, F., Fritz, L. C., Trapani, J. A., Tomaselli, K. J., Litwack, G., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7464 · Cited by 733
Fraser, A., & Evan, G. (1996) · Cell · doi:10.1016/s0092-8674(00)81005-3 · Cited by 638
Molecular Ordering of the Cell Death Pathway
Chinnaiyan, A. M., Orth, K., O'Rourke, K., Duan, H., Poirier, G. G., & Dixit, V. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.4573 · Cited by 574
Takahashi, A., Alnemri, E. S., Lazebnik, Y. A., Fernandes-Alnemri, T., Litwack, G., Moir, R. D., Goldman, R. D., Poirier, G. G., Kaufmann, S. H., & Earnshaw, W. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8395 · Cited by 518
Self-citationLazebnik, Y. A., Takahashi, A., Moir, R. D., Goldman, R. D., Poirier, G. G., Kaufmann, S. H., & Earnshaw, W. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9042 · Cited by 512
Self-citationOrth, K., Chinnaiyan, A. M., Garg, M., Froelich, C. J., & Dixit, V. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16443 · Cited by 456
Human lung carcinomas express Fas ligand.
Niehans, G. A., Brunner, T., Frizelle, S. P., Liston, J. C., Salerno, C. T., Knapp, D., Green, D. R., & Kratzke, R. A. (1997) · PubMed · Cited by 395
Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis.
Wang, X., Zelenski, N. G., Yang, J., Sakai, J., Brown, M. S., & Goldstein, J. L. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00438.x · Cited by 313
ICE/CED3-like Proteases as Therapeutic Targets for the Control of Inappropriate Apoptosis
Nicholson, D. W. (1996) · Nature Biotechnology · doi:10.1038/nbt0396-297 · Cited by 265
Apoptosis Biochemical events and relevance to cancer chemotherapy
Sen, S., & D'Incalci, M. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80914-3 · Cited by 236
The Role of APO‐1‐Mediated Apoptosis in the Immune System
Krammer, P. H., Dhein, J., Walczak, H., Behrmann, I., Mariani, S., Matiba, B., Fath, M., Daniel, P. T., Knipping, E., Westendorp, M. O., et al. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00889.x · Cited by 225
Martins, L. M., Kottke, T., Mesner, P. W., Basi, G. S., Sinha, S., Frigon, N., Tatar, E., Tung, J. S., Bryant, K., Takahashi, A., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7421 · Cited by 203
Self-citationTyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis.
Eischen, C. M., Dick, C. J., & Leibson, P. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.5.1947 · Cited by 174
Self-citationDatta, R., Banach, D. L., Kojima, H., Talanian, R., Alnemri, E., Wong, W., & Kufe, D. W. (1996) · Blood · doi:10.1182/blood.v88.6.1936.bloodjournal8861936 · Cited by 162
Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways.
Dubrez, L., Savoy, I., Hamman, A., & Solary, E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00935.x · Cited by 159
Chemotherapy-Induced Apoptosis
Mesner, P. W., Budihardjo, I. I., & Kaufmann, S. H. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)61069-8 · Cited by 158
Self-citationBertrand, R., Sarang, M., Jenkin, J., Kerrigan, D., & Pommier, Y. G. (1991) · PubMed · Cited by 135
Topoisomerase II levels during granulocytic maturation in vitro and in vivo.
Kaufmann, S. H., McLaughlin, S. J., Kastan, M. B., Liu, L. F., Karp, J. E., & Burke, P. J. (1991) · PubMed · Cited by 97
Self-citationLotem, J., & Sachs, L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12507 · Cited by 84
Eischen, C. M., Williams, B. L., Zhang, W., Samelson, L. E., Lynch, D. H., Abraham, R. T., & Leibson, P. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1135 · Cited by 57
Self-citationMoreno, M. B., Memon, S. A., & Zacharchuk, C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.9.3845 · Cited by 48
Eischen, C. M., & Leibson, P. J. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61056-x · Cited by 29
Self-citationDeath and Dying in the Immune System
Ucker, D. S. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61059-5 · Cited by 17
Cited by
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis
Earnshaw, W. C., Martins, L. M., & Kaufmann, S. H. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.383 · Cited by 2,760
Self-citationExtrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
Fulda, S., & Debatin, K.-M. (2006) · Oncogene · doi:10.1038/sj.onc.1209608 · Cited by 2,312
Strasser, A., O'Connor, L., & Dixit, V. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.217 · Cited by 1,351
Induction of Apoptosis by Cancer Chemotherapy
Kaufmann, S. H., & Earnshaw, W. C. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4838 · Cited by 1,266
Self-citation
Metadata
- Authors
- Eischen, C. M., Kottke, T. J., Martins, L. M., Basi, G. S., Tung, J. S., Earnshaw, W. C., Leibson, P. J., & Kaufmann, S. H.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1997-08-01
- Volume
- 90
- Issue
- 3
- Pages
- 935-943
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1629770860
- Cited by
- 269
- References
- 36
- FWCI
- 11.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.